The Medicines Co’s Fibrocaps Under U.S. Review
moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]
MDCO
THE MEDICINES COMPANY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $150,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Medicines Company – MDCO
[Marketwired] – Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 22, 2014 to file lead plaintiff applications in a securities … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, […]
2:28 am The Medicines Co presents analysis of EUROMAX and HORIZONS-AMI trials of Angiomax; results consistent with previous results
moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]
Update on Angiomax(R) (Bivalirudin) Patent Litigation
[Marketwired] – The Medicines Company — On March 31, 2014, Judge Andrews in the U.S. District Court of Delaware issued his Trial Opinion in The Medicines Company v. Hospira, Inc. The case involves Hospira’s Abbreviated … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here […]
The Medicines Co. shares lower after rival bacteria drugs gain FDA traction
moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]
The Medicines Co. presents analysis of Angiomax trials at ACC
moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]
Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14
[Marketwired] – The Medicines Company today reported a presentation of a pooled analysis of 5,800 patients in the EUROMAX and HORIZONS-AMI trials, two international clinical trials comparing Angiomax® versus heparin with … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]
ALERT: The Rosen Law Firm Reminds The Medicines Company Investors of Important April 22, 2014 Class Action Deadline– MDCO
[GlobeNewswire] – NEW YORK — The Rosen Law Firm, P.A. reminds purchasers of the securities of The Medicines Company between February 20, 2013 and February 12. 2014, of the important April 22, 2014 lead plaintiff deadline…. moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here […]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against THE MEDICINES COMPANY and Its Board of Directors and a Lead Plaintiff Deadline of April 22, 2014 — MDCO
[GlobeNewswire] – NEW YORK — Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased The Medicines … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, […]
/ CORRECTION – Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In The Medicines Company To Contact The Firm
[Marketwired] – In the news release, Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In The Medicines Company To Contact The Firm, issued earlier today, please … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]
